TLX250-CDx Shows Potential Utility in ccRCC Staging: New ZIRCON Phase III Data Presented in Australia.

New data demonstrates the ability of TLX250-CDx to detect extrarenal lesions, supporting potential clinical utility in the metastatic or recurrent setting,...

June 27, 2023 | Tuesday | News
First Patient Dosed in Telix's Phase II STARBURST Study Expanding TLX250-CDx Indication in Australia

The STARBURST study (ClinicalTrials.gov Identifier: NCT05563272) is a prospective, open label Phase II "basket" study to investigate CAIX expression in pat...

June 19, 2023 | Monday | News
PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA to the University of Sydney

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF, a biotechnology company focused on the researc...

June 19, 2023 | Monday | News
Propanc Biopharma Announces Strategic Pharma Partnering Initiative

Over the past several years, management has initiated discussions with potential strategic collaborators to provide the resources to advance PRP into clini...

June 07, 2023 | Wednesday | News
Chimeric Announces Launch of New Phase 1B Glioblastoma Clinical Trial

New CHM 1101 (CLXT CAR T) multi-center clinical trial activated at Sarah Cannon Research Institute (SCRI) in Austin, Texas Enrolment now open to patient...

June 05, 2023 | Monday | News
Australian Researchers Finalists for European Inventor Award 2023 with Thought-Controlled Brain-Computer Interface

Oxley and Opie's invention, the Synchron Switch™, is an endovascular brain implant designed to record or stimulate the brain or nerves from within th...

May 31, 2023 | Wednesday | News
Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study

Appointment of Charles River Laboratories ("Charles River") to run Immutep’s preclinical toxicology study evaluating the safety and toxicity of IMP...

May 30, 2023 | Tuesday | News
Sun Pharma and Philogen Partner for Exclusive Distribution, License, and Supply of NIDLEGY™ in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

May 30, 2023 | Tuesday | News
Alliance Pharma and Drug Development Solutions Are Now Resolian

“Resolian merges expertise from Alliance Pharma and Drug Development Solutions — two leading providers of bioanalysis and analytical sciences &...

May 19, 2023 | Friday | News
First Long COVID Diagnostic Test Launches Across Australia

The first diagnostic test for long COVID is now available to patients across Australia. The test can help physicians diagnose long COVID by differentiating...

May 17, 2023 | Wednesday | News
Junshi Biosciences and Dr. Reddy's Partner to Develop Toripalimab in 21 Countries.

“We are thrilled to have established a partnership with Dr. Reddy’s while toripalimab’s global commercial network has been steadily expan...

May 08, 2023 | Monday | News
Alphyn Biologics Reports Positive Pediatric Results from Phase 2a Atopic Dermatitis Trial

Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced positive results today from the pedia...

May 05, 2023 | Friday | News
PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health

PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce the establishment of a 50:50 joint venture, "Cortexa", with Austr...

May 02, 2023 | Tuesday | News
The Clinician to participate at Digital Health Festival 2023 in Melbourne

As a sponsor of the event, The Clinician team will be showcasing their healthcare solutions on the exhibition floor at booth F18 and will be hosting a dedi...

May 01, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close